Literature DB >> 6306334

The metabolic basis of familial hypercholesterolemia.

N B Myant.   

Abstract

Familial hypercholesterolaemia (FH) is a dominantly inherited error of metabolism characterised by a raised plasma low-density lipoprotein (LDL) concentration, xanthomas of skin and tendons, and a tendency to premature heart disease due to atherosclerosis of the coronary arteries. The clinical and biochemical abnormalities are more marked in homozygotes than in heterozygotes. Other biochemical changes include an increased concentration of very-low-density lipoprotein (VLDL) remnants and of a minor subfraction of high-density lipoproteins. Measurement of plasma lipoprotein turnover shows reduced fractional rates of catabolism of LDL and VLDL remnants, and increased production of LDL. Similar abnormalities are found in Watanabe rabbits, an inbred strain carrying a mutation similar to that responsible for FH. Cultured cells from human and animal tissues express surface receptors with high binding affinity for LDL. Binding of LDL to LDL receptors is followed by endocytosis and lysosomal digestion of the lipoprotein. Cultured cells from FH heterozygotes express only half the normal number of LDL receptors; those from homozygotes have little or no receptor activity and are therefore unable to degrade significant amounts of LDL by the LDL-receptor pathway. The LDL receptor has been isolated from cell membranes; it has a molecular weight of about 160 kd. Several different mutant forms of the receptor have been identified in the cells of FH homozygotes. The LDL-receptor pathway for the catabolism of LDL accounts for at least 1/3 of the total LDL catabolised by normal human subjects in vivo and almost none of that catabolised by FH homozygotes. Deficiency of LDL receptors accounts for the increased plasma concentrations of LDL and VLDL remnants in FH. The increased plasma concentration in these lipoproteins is the cause of deposition of lipid in xanthomas and arterial wall, but the mechanism by which lipoprotein enters the cells in which lipid accumulates is not yet understood.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306334     DOI: 10.1007/bf01488153

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  101 in total

1.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

2.  Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver.

Authors:  B C Sherrill; J M Dietschy
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

3.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

4.  Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia.

Authors:  H Tolleshaug; J L Goldstein; W J Schneider; M S Brown
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

5.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.

Authors:  P Mistry; N E Miller; M Laker; W R Hazzard; B Lewis
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

7.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote.

Authors:  R G Anderson; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat.

Authors:  S Balasubramaniam; J L Goldstein; J R Faust; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Authors:  R W Mahley; D Y Hui; T L Innerarity; K H Weisgraber
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  3 in total

1.  The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.

Authors:  K Steyn; M J Weight; B R Dando; K J Christopher; J E Rossouw
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

2.  MRI and histopathologic study of a novel cholesterol-fed rabbit model of xanthogranuloma.

Authors:  Yuanxin Chen; Amanda M Hamilton; Katie M Parkins; Jian-Xiong Wang; Kem A Rogers; Michael M Zeineh; Brian K Rutt; John A Ronald
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

3.  Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.

Authors:  L Izem; E Rassart; L Kamate; L Falstrault; D Rhainds; L Brissette
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.